Stockreport

Spectrum Pharmaceuticals Initiates Same Day Dosing Clinical Trial for ROLONTIS® (eflapegrastim)

Spectrum Pharmaceuticals, Inc.  (SPPI) 
Last spectrum pharmaceuticals, inc. earnings: 2/27 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.sppirx.com/investor-relations
PDF HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today anno [Read more]